We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.

Durham Research Online
You are in:

The regulation of hybrids and chimeras in the UK.

Beyleveld, D. and Finnegan, T. and Pattinson, Shaun D. (2009) 'The regulation of hybrids and chimeras in the UK.', in Chimbrids : chimeras and hybrids in comparative European and international research : scientific, ethical, philosophical and legal aspects. Berlin: Springer, pp. 603-825. Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim. (34).


In this report, we will, for the most part, sidestep discussion of how “chimeras” and “hybrids” are to be defined and distinguished, by simply focusing on the UK’s regulation of the activities that CHIMBRIDS has identified as its concern. These are activities that involve “the fusion of human and non-human tissue and cells”, and include human/non-human: * transplantation (i.e. xenotransplantation) * gamete mixing * somatic cell nuclear transfer (into an enucleated ovum) * zygote genetic modification * embryonic cell transfer/fusion. We will address each of these possibilities before addressing patent regulation and the wider ethico-cultural background of the UK regulatory position.

Item Type:Book chapter
Full text:(AM) Accepted Manuscript
Download PDF
Publisher Web site:
Publisher statement:The original publication is available at
Date accepted:No date available
Date deposited:11 September 2012
Date of first online publication:2009
Date first made open access:No date available

Save or Share this output

Look up in GoogleScholar